A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the Hip

Completed · Phase 3

Conditions studied: Osteoarthritis, Hip, Musculoskeletal Diseases

In brief

This is a clinical study to investigate the safety and efficacy of Synvisc and Depo-Medrol in treating patients with osteoarthritis (OA) of the hip.

Key facts

Study ID
NCT00131326
Run by
Genzyme, a Sanofi Company
Starts
2003-11-01
Expected to finish
2006-04-01
Last updated by the study team
2017-07-31

Who can join

Age: 35 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.